#jupiter-neurosciences
Latest news and interesting information about jupiter-neurosciences.
Jupiter Neurosciences Losses Exceeded Estimates
Jupiter Neurosciences first-quarter losses missed analyst estimates. Revenue of $18.65K fell short of $225K consensus. Stock price has dropped sharply.
Jupiter Stock Surges on MDMA Therapy Deal
Jupiter Neurosciences stock surges 75.9% on MDMA therapy licensing deal. ALA-002 is a next-generation formulation.
...

